BENDAMUSTINE HYDROCHLORIDE, CYCLOPHOSPHAMIDE, DJI136, FLUDARABINE PHOSPHATE, TOCILIZUMAB clinical trials

A Phase I/II open label study of DJI136, a DLL3-targeted CAR-T therapy, in adult patients with ES-SCLC

This study is testing a new type of treatment called DJI136, a CAR-T therapy, for people with advanced small cell lung cancer. It's in early stages to see how safe and effective it is. Researchers are looking at side effects and how well patients respond to the treatment.